A carregar...
Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD)
BACKGROUND: People with chronic obstructive pulmonary disease (COPD) have poor quality of life, reduced survival, and accelerated decline in lung function, especially associated with acute exacerbations, leading to high healthcare costs. Long‐acting bronchodilators are the mainstay of treatment for...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2017
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481854/ https://ncbi.nlm.nih.gov/pubmed/28631387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011897.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|